VIVOS THERAPEUTICS INC (VVOS)
US92859E2072 - Common Stock
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -12.57M | -13.58M | -23.85M | -20.29M | -12.06M | |||
| Depreciation Amortization | 588.00K | 621.00K | 670.00K | 730.00K | 720.00K | |||
| Change In Working Capital | -1.72M | 2.86M | 1.71M | 30.00K | -430.00K | |||
| Interest Paid | N/A | 0.00 | 0.00 | 20.00K | 30.00K | |||
| Taxes Paid | N/A | N/A | N/A | 0.00 | 0.00 | |||
| Other non cash items | 1.19M | -1.85M | 1.88M | 3.79M | 6.09M | |||
| OPERATING CASH FLOW | -12.50M | -11.95M | -19.59M | -15.74M | -5.68M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -566.00K | -803.00K | -920.00K | -2.40M | -120.00K | |||
| Other Investing Activity | N/A | -50.00K | 0.00 | -210.00K | 0.00 | |||
| INVESTING CASH FLOW | -566.00K | -853.00K | -920.00K | -2.61M | -120.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | 0.00 | -30.00K | 1.19M | |||
| Stock Issued/Repurchased | 19.74M | 12.00M | 0.00 | 26.43M | 22.59M | |||
| Other Financing Activity | -1.34M | -1.08M | 0.00 | -2.24M | -250.00K | |||
| FINANCING CASH FLOW | 18.39M | 10.92M | 0.00 | 24.17M | 23.54M | |||
| CHANGE IN CASH | 5.32M | -1.88M | -20.51M | 5.82M | 17.74M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -12.50M | -11.95M | -19.59M | -15.74M | -5.68M | |||
| Capital Expenditure | -566.00K | -803.00K | -920.00K | -2.40M | -120.00K | |||
| FREE CASH FLOW | -13.06M | -12.75M | -20.51M | -18.14M | -5.80M | |||
All data in USD